July 30, 2014. On behalf of the National Center for Health Research, I am pleased to have the opportunity to express our views on the proposed order on the reclassification of certain surgical mesh devices and surgical instruments. Our nonprofit Center analyzes and reviews research on a range of treatment issues, and provides objective and understandable information to patients and providers.
Read More »On Medical Treatments & Products
NCHR Testimony to the Obstetrics and Gynecology Devices Panel Morcellation Devices for Uterine Fibroid Removal
July 11, 2014. We need higher standards to ensure that morcellation devices are safe and effective, and that require clinical trials with sufficient numbers of patients to determine the risks of rare but fatal outcomes.
Read More »Statement of Dr. Diana Zuckerman Regarding Antidepressant Warnings
June 19, 2014. A new study claiming to show that antidepressant warnings have backfired has resulted in media quoting researchers’ speculation as if it is fact. It isn’t.
Read More »NCHR Testimony to FDA on VBLOC MAESTRO Device
June 17, 2014. We all know that obesity is often debilitating. The VBLOC device is an innovative way of addressing this important health concern but the question is: how well does it work and does its benefits outweigh its risks?
Read More »Statement of Dr. Diana Zuckerman on FDA’s Proposed Order for Pelvic Mesh
April 30, 2014. We strongly support the FDA decision to require proof of safety and effectiveness of surgical mesh for pelvic organ prolapse (POP) in clinical trials.
Read More »